EGFR and lung adenocarcinoma: To validate the SensiScreen® EGFR Liquid assays - c.2369C>T (p.T790M), exon 19 deletions, c.2573T>G/c.2573_2574TG>GT (p.L858R)—in the clinical setting, we used cfDNA extracted from blood of two retrospective cohorts including lung adenocarcinoma (AC) patients with or without metastases (S1A and S1B Table).